camelida
produc
convent
antibodi
compos
two
heavi
two
light
chain
also
antibodi
compos
heavi
chain
although
convent
antibodi
chain
contribut
antigen
bind
site
antigen
bind
site
camelid
heavychainonli
antibodi
hcab
form
singl
heavi
chain
variabl
domain
vhh
previous
gener
transgen
mice
contain
hybrid
llamahuman
antibodi
loci
two
llama
variabl
vhh
region
human
j
andor
constant
region
loci
rearrang
product
rescu
b
cell
develop
effici
heavychainonli
antibodi
express
high
level
camelid
transgen
mice
provid
domain
delet
constant
region
hcab
product
requir
igm
stage
effect
preb
cell
signal
antigenspecif
heavychainonli
igg
produc
upon
immun
camelid
vhh
segment
solubl
attribut
presenc
germ
lineencod
tetrad
specif
hydrophil
amino
acid
substitut
hydrophob
interfac
convent
vh
domain
normal
interact
variabl
light
chain
domain
vl
loop
fold
vhh
cover
side
domain
normal
interact
vl
domain
contrast
human
vh
domain
usual
aggreg
less
stabl
due
exposur
hydrophob
amino
acid
former
interfac
loss
contact
v
region
respect
limit
applic
see
rosenberg
fahrner
et
al
howev
extens
engin
select
mainli
increas
hydrophil
vh
domain
replac
expos
hydrophob
residu
region
increas
solubl
vh
domain
method
disadvantag
requir
extens
work
amino
acid
chang
particularli
region
could
reduc
chang
specif
affin
antigen
bind
hypothes
mous
would
much
effect
engin
vivo
natur
process
select
therefor
introduc
fulli
human
hcab
locu
mice
gener
fulli
human
hcab
differ
class
fragment
thereof
respons
antigen
challeng
use
therapeut
agent
man
end
replac
llama
vhh
domain
human
vh
domain
transgen
construct
use
janssen
et
al
gener
number
transgen
line
deriv
number
hcab
differ
antigen
hybridoma
phage
display
technolog
hybridoma
phage
display
technolog
number
disadvantag
quit
labori
addit
phage
display
need
addit
fullformat
hcab
reclon
eukaryot
system
known
longterm
product
ab
maintain
combin
shortliv
longliv
plasma
cell
pc
usual
defin
function
absecret
cell
asc
although
shortliv
asc
die
within
day
ab
level
maintain
continu
prolifer
differenti
memori
b
cell
mbc
shortliv
asc
upon
continu
reactiv
persist
antigen
exposur
altern
longterm
product
ab
maintain
longliv
asc
migrat
surviv
nich
within
bone
marrow
spleen
thu
use
antibodysecret
pc
bone
marrow
spleen
immun
mice
contain
human
hcab
locu
enrich
rna
sourc
product
express
librari
describ
automat
altern
method
rapid
clone
identif
antigenspecif
hcab
immun
transgen
mice
carri
fulli
human
heavi
chain
locu
clone
vdj
region
hcab
cdna
directli
mammalian
express
vector
identifi
human
embryon
kidney
clone
secret
antigenspecif
hcab
see
figur
transgen
mice
control
wildtyp
wt
mice
immun
accord
protocol
approv
dutch
experiment
anim
committe
dec
nr
eur
briefli
mice
inject
ip
five
time
interv
influenza
viru
hemagglutinin
ha
prepar
describ
ruigrok
et
al
dissolv
phosphatebuff
salin
pb
ph
use
stimun
adjuv
prionic
switzerland
accord
formul
provid
supplier
last
inject
without
adjuv
four
day
last
inject
mice
sacrif
pc
isol
singlecel
suspens
prepar
spleen
femur
bsa
mm
edta
pb
cell
count
burk
chamber
magnet
cell
sort
cell
perform
use
mous
plasma
isol
kit
miltenyi
biotec
gmbh
germani
accord
manufactur
instruct
basic
consist
two
step
first
deplet
nonpc
indirect
magnet
label
cell
nonpc
deplet
cocktail
antibiotin
microbead
follow
magnet
separ
use
ld
column
miltenyi
biotec
gmbh
germani
next
step
posit
select
pc
direct
label
microbead
follow
magnet
separ
ms
column
miltenyi
biotec
gmbh
germani
pc
elut
column
spun
pellet
resuspend
rna
reagent
biotecx
laboratori
inc
houston
tx
usa
total
rna
made
accord
manufactur
instruct
rna
dissolv
use
reaction
volum
first
strand
cdna
synthesi
use
ii
rt
invitrogen
fisher
scientif
usa
accord
instruct
use
oligo
dt
prime
oligo
dt
primer
invitrogen
life
technolog
usa
transgen
mice
contain
four
differ
vh
henc
three
differ
leaderspecif
primer
design
contain
pvuii
site
uniqu
final
express
vector
pcag
hygro
pcag
hygro
contain
leader
sequenc
follow
use
use
primer
previous
use
describ
phage
display
librari
addit
primer
use
primer
constant
region
common
howev
combin
amplifi
make
sure
vh
repres
librari
primer
use
separ
combin
primer
product
mix
equimolar
ratio
later
pcr
perform
highfidel
dna
polymeras
new
england
biolab
inc
usa
use
cycl
condit
recommend
manufactur
threestep
protocol
anneal
temperatur
cycl
total
pcr
product
cut
either
pvuiibsteii
pvuiibsrgi
uniqu
site
constant
region
amplifi
fragment
origin
use
combin
primer
clone
pvuiibsteii
pvuiibsrgi
cut
phosphatasetr
pcaghygro
vector
pcr
product
digest
pvuiibsteii
pvuiisaci
clone
pvuiibsteii
cut
phosphatasetr
pcaghygro
pvuiisaci
cut
phosphatasetr
pcaghygro
vector
pcaghygro
pcag
hygro
depict
figur
short
vector
contain
ampicillin
resist
gene
bacteria
select
hygromycin
resist
eukaryot
cell
select
hcab
express
driven
ubiquit
cmv
enhanc
chicken
beta
actin
promot
human
vh
leader
respons
secret
antibodi
constant
region
delet
exon
ligat
done
overnight
total
volum
use
ng
vector
alon
control
combin
ng
insert
use
ligas
promega
madison
wi
usa
ligat
dilut
ligat
use
transform
electrocompet
megax
cell
invitrogen
life
technolog
grand
island
ny
usa
accord
instruct
provid
manufactur
plate
done
agar
plate
individu
coloni
pick
ml
medium
format
total
dna
plasmid
prepar
done
use
nucleospin
flash
machereynagel
germani
design
rapid
manual
autom
dna
prepar
high
lowcopi
plasmid
bac
dna
escherichia
coli
dna
dissolv
steril
total
ng
dna
estim
dna
prepar
base
random
sampl
concentr
measur
use
transfect
hek
cell
hek
cell
plate
plate
transfect
use
invitrogen
carlsbad
ca
usa
accord
manufactur
instruct
format
follow
day
medium
remov
replac
dmem
medium
lonza
belgium
supplement
hygromycin
roch
diagnost
gmbh
germani
concentr
nonessenti
amino
acid
neaa
lonza
belgium
fetal
calf
serum
fc
day
posttransfect
medium
taken
well
antigenspecif
enzymelink
immunosorb
assay
elisa
replac
fresh
medium
enzymelink
immunosorb
assay
plate
coat
overnight
antigen
pb
pb
block
done
h
room
temperatur
rt
milk
bsapb
wv
done
exclud
possibl
sticki
binder
plastic
nonspecif
binder
bsamilk
wash
step
includ
pb
total
transgen
mous
serum
dilut
pb
initi
test
immun
anim
supernat
hek
cell
mix
milk
bsapb
wv
incub
h
rt
wash
antigenspecif
serumsupernat
detect
incub
goat
antihuman
igg
fc
coupl
hors
radish
peroxidas
hrp
jackson
immuno
research
laboratori
inc
usa
dilut
h
rt
follow
wash
step
incub
peroxidas
substrat
bm
blue
pod
roch
diagnost
gmbh
germani
reaction
stop
absorpt
measur
nm
refer
wavelength
nm
initi
test
immun
wt
transgen
mice
sera
presenc
antigenspecif
mous
antibodi
polyclon
goat
antimous
immunoglobulin
hrp
dako
denmark
dilut
use
sequenc
posit
dna
clone
done
use
primer
cag
medium
collect
hek
cell
stabli
transfect
hcab
express
vector
grown
confluenc
screen
clone
express
highest
affin
hcab
ha
hek
cell
medium
clone
transfer
singl
well
black
microtit
plate
greiner
bioon
germani
bind
hcab
influenza
ha
studi
use
octet
qk
fortebio
usa
antihuman
iggcoat
tip
fortebio
usa
incub
establish
baselin
signal
allow
captur
hcab
tip
transfer
hek
medium
contain
hcab
hek
medium
without
hcab
refer
subsequ
tip
transfer
establish
bind
level
dissoci
nonspecif
interact
next
load
tip
transfer
nm
bromelainreleas
ha
bha
allow
ha
bind
captur
antiha
hcab
determin
dissoci
rate
ha
hcab
refer
bind
signal
subtract
bind
curv
bind
data
fit
bind
model
use
octet
softwar
hcab
clone
show
bind
initi
affin
screen
select
analysi
full
kinet
experi
perform
purifi
hcab
dialyz
pb
antihuman
igg
fc
sensor
dip
tween
hcab
use
load
step
rpm
follow
tween
associ
step
ha
ligand
concentr
rang
nm
perform
rpm
follow
dissoci
step
tween
rpm
step
done
volum
buffer
well
tween
use
refer
well
refer
bind
signal
subtract
bind
curv
bind
data
fit
bind
model
use
octet
softwar
posit
clone
expand
medium
contain
fc
altern
plasmid
dna
linear
hindiii
stabli
transfect
cell
individu
clone
pick
purpos
select
best
expressor
product
purpos
clone
grown
cm
petri
dish
ml
gibco
life
technolog
ca
usa
medium
medium
collect
replac
twice
per
week
collect
medium
spun
rpm
eppendorf
centrifug
min
remov
cell
debri
hcab
purifi
protein
agaros
fast
flow
vv
sigma
usa
total
protein
bead
incub
ml
medium
overnight
rotat
wheel
spin
rpm
min
bead
wash
load
onto
homemad
column
insulin
syring
cotton
wool
wash
pb
elut
potassium
thiocyan
kscn
elut
hcab
dialyz
h
use
spectrapor
dialysi
membran
mwco
spectrum
laboratori
inc
usa
volum
excess
pb
procedur
repeat
three
time
vh
domain
hcab
clone
without
tag
pet
sumo
vector
champion
pet
sumo
express
system
invitrogen
ca
usa
product
fusion
protein
cleavag
remov
sumo
sumo
proteas
done
accord
manufactur
instruct
recommend
reagent
vh
domain
fusion
sumo
purifi
inclus
bodi
start
ml
transfect
cell
h
induct
mm
iptg
cell
harvest
pellet
frozen
overnight
lyse
ml
lysi
buffer
mm
ph
mm
nacl
mm
kcl
glycerol
triton
sonic
ampl
spin
min
rpm
pellet
taken
ml
pb
addit
benzonas
min
rt
wash
wash
buffer
mm
tri
ph
mm
edta
urea
triton
sampl
spun
min
rpm
wash
ml
mm
tri
ph
mm
edta
pellet
taken
urea
mm
tri
ph
mm
dtt
rotat
h
rt
spun
min
rpm
supernat
use
refold
base
refold
buffer
pierc
refold
kit
use
mm
mm
tri
ph
mm
nacl
mm
kcl
protein
dilut
mgml
urea
mm
tri
ph
mm
dtt
fold
mg
protein
use
ml
base
refold
buffer
edta
mg
gsh
reduc
glutathion
mg
gssg
oxid
glutathion
ml
protein
ad
aliquot
well
mix
left
ice
least
min
addit
overnight
incub
sampl
dialyz
pb
buffer
total
hcab
concentr
end
point
volum
use
k
centrifug
filter
devic
merck
millipor
ltd
ireland
suggest
manufactur
concentr
sampl
dilut
guanidin
hydrochlorid
gdnhcl
od
nm
measur
nanodrop
spectrophotomet
thermo
scientif
ireland
procedur
use
select
vh
express
e
coli
total
purifi
pbsdialyz
hcab
pb
run
superdex
column
ge
healthcar
life
scienc
usa
fplc
smart
system
pharmacia
sampl
run
pb
biorad
gel
filtrat
standard
mixtur
molecular
weight
marker
rang
da
use
control
procedur
done
select
vh
express
e
coli
run
superdex
column
ge
healthcar
life
scienc
usa
microtit
plaqu
reduct
assay
describ
matrosovich
et
al
perform
use
cell
twofold
dilut
hcab
incub
cell
monolay
prior
addit
viru
neutral
titer
determin
reciproc
dilut
hcab
correspond
reduct
plaqu
format
compar
viru
control
hemagglutin
inhibit
assay
perform
accord
standard
method
kendal
et
al
use
turkey
guinea
pig
red
blood
cell
suspens
respect
four
ha
unit
twofold
dilut
hcab
use
assay
hi
titer
reciproc
highest
dilut
hcab
inhibit
hemagglutin
total
influenza
ha
protein
prepar
describ
ruigrok
et
al
per
mous
inject
intraperiton
week
interv
eight
transgen
mice
two
transgen
line
origin
differ
founder
differ
integr
site
transgen
two
wt
mice
control
use
stimun
adjuv
third
inject
mice
bled
elisa
assay
perform
serum
use
ha
proteinco
plate
antihuman
igghrp
antimous
igghrp
detect
haspecif
antibodi
seven
eight
transgen
mice
two
two
wt
mice
haspecif
antibodi
detect
figur
supplementari
materi
higher
amount
antigen
lead
better
respons
thu
conclud
suffici
success
immun
seven
transgen
elisa
posit
mice
immun
three
time
ha
four
day
last
inject
without
adjuv
mice
sacrif
cd
pc
isol
bone
marrow
spleen
total
rna
isol
cdna
synthes
depict
schemat
figur
human
vdj
domain
amplifi
use
set
three
differ
primer
specif
leader
sequenc
transgen
mous
construct
combin
two
differ
primer
specif
either
human
hing
due
high
sequenc
similar
primer
use
amplif
design
contain
pvuii
restrict
site
pvuii
site
appear
usual
begin
dna
encod
vh
region
third
fourth
codon
amino
acid
level
rare
occur
anywher
els
human
vh
amplifi
pcr
product
cut
either
pvuiisaci
pvuiibsteii
restrict
enzym
saci
site
uniqu
site
begin
hing
bsteii
site
frame
uniqu
vh
commonli
use
construct
phage
librari
vdj
fragment
clone
bacteria
use
either
pcaghygro
pcaghygro
express
vector
contain
ubiquit
express
chicken
promot
leader
sequenc
human
constant
region
human
figur
ligat
cdna
transfect
electrocompet
e
coli
cell
total
part
almost
avail
rna
mice
pc
isol
half
total
number
cell
total
rna
made
cdna
gel
purifi
pcr
amplifi
cdna
use
ligat
ligat
transform
transform
bacteria
plate
total
coloni
count
pick
plate
total
coloni
pick
librari
plate
fill
medium
result
recombin
bacteria
grown
overnight
plasmid
dna
prepar
format
parallel
hek
cell
also
grown
format
transfect
plasmid
dna
maintain
format
haspecif
elisa
screen
perform
supernat
well
day
transfect
yield
posit
supernatantsclon
correspond
cdna
sequenc
figur
show
two
four
avail
variabl
segment
use
preferenti
vdj
domain
contain
somat
hypermut
predominantli
use
also
found
antibodi
present
confirm
class
switch
occur
transgen
mous
preval
hcab
surpris
take
account
constant
region
proxim
transgen
construct
thu
first
recombin
sequenc
uniqu
account
differ
dj
region
base
differ
region
hcab
classifi
distinct
group
repres
differ
color
figur
posit
clone
cultur
supernat
collect
affin
screen
use
ha
antigen
prepar
twenti
four
clone
show
signific
bind
select
number
clone
base
sequenc
divers
affin
produc
serum
free
medium
antibodi
low
affin
test
function
assay
see
four
group
repres
figur
blue
green
red
yellow
left
appear
bind
epitop
appear
bind
differ
overlap
epitop
heavychainonli
antibodi
medium
purifi
protein
elut
kscn
dialyz
pb
averag
yield
estim
medium
sdspage
gel
hcab
expect
size
monom
kda
reduc
dimer
kda
nonreduc
condit
figur
size
differ
origin
differ
size
composit
vh
region
differ
size
longer
hing
hcab
account
kda
differ
per
monom
comparison
hcab
profil
size
chromatographi
smart
column
show
singl
peak
expect
size
peak
hcab
higher
molecular
weight
hcab
figur
solubl
pb
test
hcab
concentr
final
volum
select
hcab
differ
concentr
equival
mgml
normal
antibodi
figur
concentr
solubl
antibodi
test
two
vhdj
segment
also
express
bacteria
shown
solubl
least
mgml
also
equival
mgml
normal
antibodi
figur
supplementari
materi
bind
affin
hcab
determin
octet
instrument
purifi
antibodi
bha
prepar
lack
transmembran
anchor
use
prevent
rosett
format
aggreg
antigen
major
kd
valu
hcab
molar
rang
molar
rang
kd
valu
highest
affin
hcab
better
hcab
react
western
blot
nonreduc
reduc
condit
recogn
denatur
bha
monom
chain
respect
react
bha
nonreduc
condit
preferenti
recogn
reduc
condit
data
shown
ha
hcab
first
evalu
abil
neutral
influenza
viru
plaqu
reduct
assay
neutral
report
reciproc
highest
dilut
antibodi
correspond
plaqu
reduct
compar
viru
control
total
antibodi
test
show
visibl
inhibit
reduct
observ
four
hcab
tabl
modifi
neutral
experi
also
perform
antibodi
incub
min
viru
prior
addit
cell
led
increas
neutral
effect
especi
case
antibodi
neutral
ferret
anti
serum
ha
mous
monoclon
antibodi
use
posit
control
hcab
also
show
hi
perform
turkey
red
blood
cell
figur
guinea
pig
blood
data
shown
suggest
neutral
infect
obstruct
bind
viru
host
cell
describ
effici
method
obtain
fulli
human
antigenspecif
solubl
highaffin
hcab
easili
autom
approach
base
captur
antibodi
repertoir
antibodysecret
pc
bone
marrow
spleen
immun
transgen
mice
recent
laboratori
use
mous
spleen
pc
mous
bone
marrow
pc
human
peripher
blood
pc
human
mbc
patient
recov
infect
obtain
antigenspecif
monoclon
antibodi
basic
method
util
singlecel
sort
singlecel
rtpcr
natur
pair
screen
method
develop
improv
effici
enabl
detect
antigenspecif
secret
cell
singlecel
rtpcr
step
enzymelink
immunospot
immunospot
array
assay
chip
microengrav
recent
method
describ
omit
screen
step
util
massiv
dna
sequenc
bioinformat
tool
analyz
vl
vh
gene
repertoir
find
sever
abund
vh
vl
sequenc
pair
base
rel
frequenc
effici
method
combin
nextgener
sequenc
protein
mass
spectroscopi
obtain
antigenspecif
antibodi
repertoir
dekoski
colleagu
develop
lowcost
singlecel
emulsionbas
technolog
sequenc
antibodi
repertoir
even
better
pair
precis
transgen
mice
produc
human
hcab
without
light
chain
thu
pair
necess
singlecel
rtpcr
major
concern
solubl
human
vh
domain
solubl
per
se
result
show
antigenspecif
hcab
select
screen
show
high
solubl
fulllength
hcab
vh
fragment
thu
method
allow
easi
isol
solubl
vh
region
construct
multival
solubl
vh
complex
solubl
human
vh
domain
obtain
transgen
mice
present
possess
hallmark
amino
acid
chang
present
vhh
camelid
hcab
posit
reduc
hydrophob
former
light
chain
interfac
remain
germ
line
vh
g
l
w
respect
replac
v
vh
hydrophil
f
vhh
vh
domain
mutat
posit
f
one
l
hcab
germ
line
analyz
mani
sequenc
differ
immun
differ
antigen
beyond
restrict
list
anti
ha
hcab
shown
figur
seen
substitut
found
antibodi
compris
heavi
light
chain
found
increas
net
hydrophob
within
increas
number
charg
amino
acid
present
amino
acid
substitut
within
framework
sheet
lead
increas
net
hydrophob
within
increas
number
charg
amino
acid
present
could
lead
solubl
autonom
solubl
vh
domain
obtain
transgen
mice
experi
done
transgen
mice
bred
mt
heavi
chain
knockout
background
previous
report
mt
knockout
mice
produc
low
level
igg
antibodi
prolong
time
case
mous
light
chain
might
theoret
attach
human
vh
affect
solubl
could
caus
problem
use
hybridoma
fusion
reason
increas
solubl
light
chain
attach
solubl
hamper
clone
heavi
chain
vh
express
vector
produc
antibodi
would
aggreg
problem
see
use
hek
librari
knock
loci
complet
would
avoid
problem
choic
vh
transgen
construct
base
vh
usag
human
popul
also
known
solubl
llama
vhh
mostli
resembl
famili
three
human
vh
fact
particular
experi
obtain
antibodi
origin
none
could
explain
antigenrel
specif
usag
new
class
influenzaneutr
antibodi
target
conserv
site
ha
stem
vh
describ
vh
present
transgen
mous
experi
vh
region
also
use
data
shown
solubl
human
vh
domain
obtain
transgen
mice
present
possess
hallmark
amino
acid
chang
present
vhh
camelid
hcab
posit
function
reduc
hydrophob
former
light
chain
interfac
remain
germ
line
vh
situat
g
l
w
respect
four
human
vh
obtain
transgen
mice
clone
human
vector
reproduc
characterist
antibodi
circul
transgen
mous
therapeut
purpos
human
antibodi
prefer
due
effector
function
obtain
select
vh
could
clone
express
human
appropri
vector
improv
transgen
mous
platform
increas
number
germ
line
vh
construct
thu
increas
repertoir
human
constant
region
new
gener
transgen
mice
replac
mous
constant
region
report
better
suit
mous
machineri
direct
clone
might
perform
human
igg
vector
choic
pilot
experi
perform
plasmid
dna
bacteri
librari
estim
vector
contamin
plasmid
without
cdna
insert
gave
elisaposit
clone
uniqu
take
account
mice
carri
region
tini
fraction
avail
materi
use
retriev
antibodi
sequenc
repres
sampl
test
high
effici
obtain
mani
highaffin
antibodi
industri
scale
automatedrobot
process
low
cost
predict
anim
studi
describ
approv
anim
ethic
comiti
dierenexperimentencommissi
dec
immun
protocol
eur
dd
fg
js
contribut
design
experi
dd
eb
rj
rr
jk
js
contribut
acquisit
analysi
data
dd
fg
js
contribut
interpret
data
write
manuscript
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
